VI. ALTERNATIVE TREATMENTS 
You have been offered the opportunity to participate in this study after your tumor 
recurred despite appropriate standard therapies for your disease. A variety of experimental 
studies for the treatment of brain tumors are conducted in medical centers around the world, 
but the benefit of these treatments is as yet unknown. In addition, there is always the 
possibility for you to decline any further treatment for your disease. Your decision to 
participate in this study will in no way affect the availability of alternative treatments for you 
now or in the future. 
VII. NEW FINDINGS: 
Any new information acquired by your doctors during the course of this study which 
may affect your choice to participate in this research will be given to you. This includes 
information about the study procedures or consequences experienced by other patients 
involved in the study. 
VIII. CONFIDENTIALITY: 
Every effort will be made to maintain the confidentiality of your study records. Agents 
of the United States Food and Drug Administration, National Institute of Health, and 
scientists at Baylor College of Medicine, The Methodist Hospital and Texas Children's 
Hospital may be allowed to inspect sections of your medical record and research records 
related to this study. Results gathered from this study may be published, however, 
participants will not be identified by name. The confidentiality of the data will be maintained 
within legal limits. 
This clinical procedure may attract a great deal of attention from the media. We will 
make every effort to protect the confidentiality of you and your family. However, because of 
this media interest there is a greater risk than usual that information concerning your 
treatment will appear publicly without your consent. 
IX. COST AND PAYMENTS: 
You will not receive any payment for participation in this study. Treatments and any 
special research tests associated with this study will be provided at no cost to you. 
Participation in this study will represent no additional cost to your medical treatment. All 
laboratory, physician or hospital costs not related to the performance of research during this 
study will be charged to you or your insurance company as usual. In the event of injury or 
long-term disability resulting from this experimental therapy, Baylor College of Medicine and 
The Methodist Hospital are not able to offer financial compensation nor to absorb the cost of 
medical treatment and/or long-term care. However, necessary facilities, emergency 
treatment and professional service will be available to research subjects just as they are to 
the community in general. Your signature below acknowledges your voluntary participation 
in this research project. Such participation does not release the investigator, institutions, 
sponsors or granting agencies from their professional and ethical responsibilities to you. 
Recombinant DNA Research, Volume 20 
